Genmab — Juni 2018
-
Mid’18 CASSIOPIEA –frontline transplant patients, interim read out from the induction phase of the trial which could set the bar for CAR-T based competitor approaches in frontline MM –although longer follow up from the maintenance setting required
-
tak fr info stockbull
-
what stduy are they referring to here? http://www.proinvestor.com/investornyt/538291/janssen-starter-nyt-studie-med-darzalex-og-pd-1-haemmer-i-solide-tumorer
-
-
EL. They are referring to a new study. https://clinicaltrials.gov/ct2/show/NCT03547037?term=daratumumab&draw=7&rank=58
-
Basically saying that Janssen also still believe there are possibilities with this combination.
-
Er vi ikke enige om, at godkendelsen vi venter på, som muligvis er rykket, er den vi har fået i hus i US?
-
Så er der vel ingen fare på færde?
-
Forstår ikke bekymringen så?
-
Måske lidt lavere salg i år, men intet betydningsfuld på den lange bane.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind